157 related articles for article (PubMed ID: 28316053)
1. The use of rapid and cost-effective blood-based biomarkers in combination with tumour TNM stage for individual head and neck cancer patient treatment selection.
Laytragoon Lewin N; Lewin F; Andersson BÅ; Löfgren S; Rutqvist LE
Med Oncol; 2017 Apr; 34(4):63. PubMed ID: 28316053
[TBL] [Abstract][Full Text] [Related]
2. Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma.
Andersson BÅ; Lewin F; Lundgren J; Nilsson M; Rutqvist LE; Löfgren S; Laytragoon-Lewin N
J Cancer Res Clin Oncol; 2014 Mar; 140(3):515-9. PubMed ID: 24481866
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma.
Mojtahedi Z; Khademi B; Yehya A; Talebi A; Fattahi MJ; Ghaderi A
J Laryngol Otol; 2012 Feb; 126(2):175-9. PubMed ID: 21888745
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
[TBL] [Abstract][Full Text] [Related]
6. Pros and Cons of the New Edition of TNM Classification of Head and Neck Squamous Cell Carcinoma.
Denaro N; Russi EG; Merlano MC
Oncology; 2018; 95(4):202-210. PubMed ID: 29975952
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
8. Cell-free mitochondrial DNA copy number variation in head and neck squamous cell carcinoma: A study of non-invasive biomarker from Northeast India.
Kumar M; Srivastava S; Singh SA; Das AK; Das GC; Dhar B; Ghosh SK; Mondal R
Tumour Biol; 2017 Oct; 39(10):1010428317736643. PubMed ID: 29072129
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells as biomarkers of head and neck squamous cell carcinoma: an updated view.
Mangano A; Mangano A; Lianos GD; Levrini L; Picone M; Boni L; Dionigi G
Future Oncol; 2015; 11(13):1851-3. PubMed ID: 26161921
[No Abstract] [Full Text] [Related]
10. NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma.
Gupta A; Kumar R; Sahu V; Agnihotri V; Singh AP; Bhasker S; Dey S
Biochem Biophys Res Commun; 2015 Nov; 467(2):248-53. PubMed ID: 26435503
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
Valero C; Pardo L; López M; García J; Camacho M; Quer M; León X
Head Neck; 2017 Feb; 39(2):219-226. PubMed ID: 27534525
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma.
Rassouli A; Saliba J; Castano R; Hier M; Zeitouni AG
Head Neck; 2015 Jan; 37(1):103-10. PubMed ID: 24339165
[TBL] [Abstract][Full Text] [Related]
13. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
14. Macrophage colony-stimulating factor as a tumor marker for squamous cell carcinoma of the head and neck.
Kuropkat C; Dünne AA; Plehn S; Ossendorf M; Herz U; Renz H; Werner JA
Tumour Biol; 2003; 24(5):236-40. PubMed ID: 15001836
[TBL] [Abstract][Full Text] [Related]
15. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M
BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumour cells in metastatic head and neck cancers.
Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck.
Soylu L; Ozcan C; Cetik F; Paydaş S; Kiroğlu M; Aydoğan B; Sargin O; Ozşahinoglu C; Seyrek E
Am J Otolaryngol; 1994; 15(4):281-5. PubMed ID: 7978027
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma.
Goumas PD; Mastronikolis NS; Mastorakou AN; Vassilakos PJ; Nikiforidis GC
ORL J Otorhinolaryngol Relat Spec; 1997; 59(2):106-14. PubMed ID: 9166881
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen and Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hypopharyngeal Squamous Cell Carcinoma.
Kuwahara T; Takahashi H; Sano D; Matsuoka M; Hyakusoku H; Hatano T; Hiiragi Y; Oridate N
Anticancer Res; 2018 Sep; 38(9):5321-5330. PubMed ID: 30194184
[TBL] [Abstract][Full Text] [Related]
20. Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck.
Chen WC; Lai CH; Chuang HC; Lin PY; Chen MF
Head Neck; 2017 Feb; 39(2):347-355. PubMed ID: 27696591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
